Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.02−0.34 (-0.47%)
Close on Nov 17, 2026Market cap $229.30MP/E 22.0Yield –
Utah Medical Products price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Utah Medical Products's price to book ratio was 1.9× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 1.5× to 3.4×, with a median of 1.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.9× | +0.4 |
| 2025 | Dec 31, 2025 | 1.5× | −0.2 |
| 2024 | Dec 31, 2024 | 1.7× | −0.7 |
| 2023 | Dec 29, 2023 | 2.5× | −0.9 |
| 2022 | Dec 30, 2022 | 3.4× | +0.1 |
| 2021 | Dec 31, 2021 | 3.3× | +0.2 |
| 2020 | Dec 31, 2020 | 3.1× | +3.1 |
| 2019 | Dec 31, 2019 | 0.0× | +0.0 |
| 2018 | Dec 31, 2018 | 0.0× | −3.7 |
| 2017 | Dec 29, 2017 | 3.7× | −0.0 |
| 2016 | Dec 30, 2016 | 3.8× | +0.6 |
| 2015 | Dec 31, 2015 | 3.2× | −0.3 |
| 2014 | Dec 31, 2014 | 3.5× | −0.2 |
| 2013 | Dec 31, 2013 | 3.7× | +1.0 |
| 2012 | Dec 31, 2012 | 2.7× | +0.3 |
| 2011 | Dec 30, 2011 | 2.4× | – |
See a number that looks wrong?